Viewing Study NCT01373567


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-05-13 @ 2:41 PM
Study NCT ID: NCT01373567
Status: COMPLETED
Last Update Posted: 2012-11-22
First Post: 2010-12-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis
Sponsor: Piramal Enterprises Limited
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: TINEFCON/49/10
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators